David Kroll
Concepts (443)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Topoisomerases, Type II | 10 | 2005 | 45 | 1.270 |
Why?
| Antineoplastic Agents, Phytogenic | 16 | 2012 | 181 | 1.200 |
Why?
| Plant Extracts | 10 | 2010 | 153 | 0.880 |
Why?
| Silymarin | 10 | 2016 | 194 | 0.780 |
Why?
| Phytotherapy | 7 | 2010 | 66 | 0.680 |
Why?
| Antineoplastic Agents | 13 | 2016 | 1891 | 0.580 |
Why?
| Prostatic Neoplasms | 10 | 2016 | 927 | 0.550 |
Why?
| Isoenzymes | 4 | 2001 | 286 | 0.470 |
Why?
| Flavonolignans | 4 | 2009 | 10 | 0.440 |
Why?
| Camptothecin | 4 | 2009 | 97 | 0.440 |
Why?
| Hypocreales | 4 | 2013 | 8 | 0.430 |
Why?
| Drug Interactions | 5 | 2010 | 347 | 0.420 |
Why?
| Etoposide | 3 | 2001 | 149 | 0.410 |
Why?
| Drug Screening Assays, Antitumor | 16 | 2013 | 180 | 0.400 |
Why?
| Tumor Cells, Cultured | 9 | 2006 | 850 | 0.380 |
Why?
| Plants, Medicinal | 6 | 2009 | 19 | 0.370 |
Why?
| Transcriptional Activation | 4 | 1997 | 341 | 0.370 |
Why?
| DNA | 9 | 2001 | 1358 | 0.320 |
Why?
| Molecular Structure | 15 | 2013 | 447 | 0.310 |
Why?
| Anti-Bacterial Agents | 6 | 2013 | 1486 | 0.300 |
Why?
| Paclitaxel | 2 | 2009 | 192 | 0.290 |
Why?
| Biological Products | 3 | 2012 | 172 | 0.290 |
Why?
| Enzyme Inhibitors | 3 | 2012 | 758 | 0.290 |
Why?
| Cell Line, Tumor | 19 | 2016 | 2749 | 0.290 |
Why?
| Promoter Regions, Genetic | 4 | 2005 | 1129 | 0.270 |
Why?
| Terminology as Topic | 1 | 2007 | 190 | 0.270 |
Why?
| Topoisomerase II Inhibitors | 2 | 2005 | 23 | 0.260 |
Why?
| Plant Proteins | 2 | 2004 | 80 | 0.240 |
Why?
| Colchicum | 3 | 2010 | 3 | 0.220 |
Why?
| Butyrates | 2 | 2001 | 53 | 0.220 |
Why?
| Peptaibols | 2 | 2013 | 2 | 0.220 |
Why?
| Terphenyl Compounds | 2 | 2013 | 3 | 0.220 |
Why?
| Indole Alkaloids | 2 | 2012 | 9 | 0.210 |
Why?
| DNA-Binding Proteins | 5 | 2005 | 1319 | 0.210 |
Why?
| Antigens, Neoplasm | 5 | 2005 | 224 | 0.210 |
Why?
| Transfection | 5 | 2000 | 866 | 0.210 |
Why?
| Sesquiterpenes | 2 | 2013 | 51 | 0.210 |
Why?
| Hypericum | 1 | 2001 | 2 | 0.200 |
Why?
| Herbal Medicine | 1 | 2001 | 4 | 0.200 |
Why?
| Antifungal Agents | 2 | 2013 | 134 | 0.200 |
Why?
| Terpenes | 1 | 2001 | 23 | 0.200 |
Why?
| Mixed Function Oxygenases | 1 | 2001 | 37 | 0.200 |
Why?
| Benzene | 1 | 2001 | 19 | 0.200 |
Why?
| Thylakoids | 1 | 2001 | 3 | 0.190 |
Why?
| Hemostasis | 1 | 2001 | 67 | 0.190 |
Why?
| Drug Carriers | 3 | 1998 | 113 | 0.190 |
Why?
| Biomedical Research | 1 | 2007 | 590 | 0.190 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2001 | 108 | 0.190 |
Why?
| Aryl Hydrocarbon Hydroxylases | 2 | 2012 | 41 | 0.190 |
Why?
| Genes, Plant | 1 | 2001 | 43 | 0.190 |
Why?
| Neoplasms | 4 | 2009 | 2111 | 0.190 |
Why?
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 274 | 0.190 |
Why?
| Antioxidants | 4 | 2016 | 533 | 0.190 |
Why?
| Dietary Supplements | 1 | 2004 | 460 | 0.180 |
Why?
| Dose-Response Relationship, Drug | 7 | 2012 | 1868 | 0.180 |
Why?
| Arabidopsis Proteins | 1 | 2001 | 60 | 0.180 |
Why?
| NF-kappa B | 4 | 2012 | 639 | 0.180 |
Why?
| Arabidopsis | 1 | 2001 | 69 | 0.180 |
Why?
| Liposomes | 2 | 1998 | 149 | 0.180 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2001 | 198 | 0.180 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2016 | 399 | 0.170 |
Why?
| Ericales | 1 | 1999 | 2 | 0.170 |
Why?
| Diterpenes | 3 | 2009 | 32 | 0.170 |
Why?
| Cell Cycle Proteins | 3 | 2008 | 555 | 0.170 |
Why?
| Theophylline | 1 | 1999 | 60 | 0.160 |
Why?
| Humans | 54 | 2016 | 115890 | 0.160 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 8 | 2013 | 238 | 0.160 |
Why?
| Magnoliopsida | 1 | 1998 | 27 | 0.160 |
Why?
| Annonaceae | 2 | 2009 | 4 | 0.160 |
Why?
| Receptors, Androgen | 2 | 2010 | 132 | 0.150 |
Why?
| beta-Galactosidase | 1 | 1997 | 63 | 0.150 |
Why?
| Nuclear Proteins | 3 | 2007 | 594 | 0.150 |
Why?
| Cloning, Molecular | 2 | 2001 | 522 | 0.150 |
Why?
| Bronchodilator Agents | 1 | 1999 | 251 | 0.140 |
Why?
| Enhancer of Zeste Homolog 2 Protein | 1 | 2016 | 37 | 0.140 |
Why?
| Practice Guidelines as Topic | 1 | 2004 | 1403 | 0.140 |
Why?
| Transcription Factors | 5 | 2016 | 1530 | 0.140 |
Why?
| Fungi | 3 | 2011 | 124 | 0.130 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2016 | 59 | 0.130 |
Why?
| Colchicine | 2 | 2006 | 24 | 0.130 |
Why?
| Cyclic AMP Response Element-Binding Protein | 2 | 1993 | 128 | 0.130 |
Why?
| Leukemia, Promyelocytic, Acute | 1 | 1995 | 12 | 0.130 |
Why?
| Plasmids | 2 | 1993 | 346 | 0.130 |
Why?
| HeLa Cells | 5 | 1997 | 568 | 0.120 |
Why?
| Cell Cycle | 3 | 2007 | 546 | 0.120 |
Why?
| Membrane Proteins | 1 | 2001 | 1033 | 0.120 |
Why?
| COS Cells | 4 | 2000 | 176 | 0.120 |
Why?
| Microbial Sensitivity Tests | 6 | 2013 | 299 | 0.120 |
Why?
| Antiviral Agents | 2 | 2012 | 648 | 0.120 |
Why?
| Lipids | 1 | 1998 | 589 | 0.120 |
Why?
| Gene Expression | 2 | 2005 | 1442 | 0.120 |
Why?
| Trans-Activators | 1 | 1997 | 369 | 0.120 |
Why?
| Trichothecenes | 2 | 2011 | 4 | 0.120 |
Why?
| Isocoumarins | 1 | 2013 | 1 | 0.110 |
Why?
| Recombinant Fusion Proteins | 2 | 1993 | 616 | 0.110 |
Why?
| Molecular Sequence Data | 7 | 2001 | 2793 | 0.110 |
Why?
| Pyrrolidinones | 1 | 2013 | 25 | 0.110 |
Why?
| Proto-Oncogene Proteins | 1 | 1997 | 609 | 0.110 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 1143 | 0.110 |
Why?
| Phosphodiesterase 4 Inhibitors | 1 | 2013 | 2 | 0.110 |
Why?
| Aldehydes | 3 | 1999 | 146 | 0.110 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2013 | 7 | 0.110 |
Why?
| Apoptosis | 4 | 2010 | 2377 | 0.110 |
Why?
| Structure-Activity Relationship | 5 | 2012 | 510 | 0.110 |
Why?
| Ascomycota | 1 | 2013 | 27 | 0.110 |
Why?
| Drug Stability | 3 | 2009 | 152 | 0.110 |
Why?
| Herb-Drug Interactions | 2 | 2009 | 4 | 0.110 |
Why?
| Anthelmintics | 1 | 2012 | 9 | 0.110 |
Why?
| Benzoquinones | 1 | 2013 | 44 | 0.110 |
Why?
| Disulfides | 1 | 2012 | 91 | 0.100 |
Why?
| Monocytes | 1 | 1995 | 504 | 0.100 |
Why?
| Xanthones | 1 | 2011 | 2 | 0.100 |
Why?
| Anthraquinones | 1 | 2011 | 9 | 0.100 |
Why?
| Depsipeptides | 1 | 2011 | 13 | 0.100 |
Why?
| Cyanobacteria | 1 | 2012 | 54 | 0.100 |
Why?
| Cyclin-Dependent Kinases | 3 | 2008 | 110 | 0.100 |
Why?
| Zearalenone | 1 | 2011 | 2 | 0.100 |
Why?
| Hepacivirus | 1 | 2012 | 234 | 0.090 |
Why?
| Drug Discovery | 1 | 2012 | 124 | 0.090 |
Why?
| Lactones | 1 | 2011 | 56 | 0.090 |
Why?
| Macrocyclic Compounds | 1 | 2010 | 9 | 0.090 |
Why?
| Drug Evaluation, Preclinical | 2 | 2010 | 165 | 0.090 |
Why?
| Piperazines | 1 | 2012 | 313 | 0.090 |
Why?
| Animals | 20 | 2012 | 32120 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 3 | 1997 | 313 | 0.090 |
Why?
| Acclimatization | 1 | 1990 | 126 | 0.080 |
Why?
| Leukemia | 2 | 2001 | 207 | 0.080 |
Why?
| Melanoma, Experimental | 1 | 1990 | 118 | 0.080 |
Why?
| Base Sequence | 6 | 1999 | 2120 | 0.080 |
Why?
| Staphylococcus aureus | 1 | 2013 | 386 | 0.080 |
Why?
| Ginkgo biloba | 1 | 2009 | 6 | 0.080 |
Why?
| Recombinant Proteins | 4 | 2009 | 1243 | 0.080 |
Why?
| Plant Preparations | 1 | 2009 | 23 | 0.080 |
Why?
| Amino Acid Sequence | 4 | 2001 | 2000 | 0.080 |
Why?
| Warfarin | 1 | 2009 | 136 | 0.080 |
Why?
| Echium | 1 | 2008 | 1 | 0.080 |
Why?
| Hot Temperature | 1 | 1990 | 302 | 0.080 |
Why?
| Pyrrolizidine Alkaloids | 1 | 2008 | 14 | 0.080 |
Why?
| Glutathione Transferase | 2 | 1999 | 96 | 0.080 |
Why?
| Chemical and Drug Induced Liver Injury | 1 | 2010 | 126 | 0.080 |
Why?
| Mercuric Chloride | 1 | 1988 | 2 | 0.080 |
Why?
| ErbB Receptors | 2 | 2012 | 557 | 0.080 |
Why?
| Prostate-Specific Antigen | 2 | 2008 | 152 | 0.080 |
Why?
| Protective Agents | 1 | 2008 | 38 | 0.080 |
Why?
| Epoxide Hydrolases | 1 | 1988 | 10 | 0.080 |
Why?
| Microsomes | 1 | 1988 | 24 | 0.080 |
Why?
| Quaternary Ammonium Compounds | 2 | 1998 | 46 | 0.080 |
Why?
| Immunoconjugates | 1 | 2009 | 87 | 0.080 |
Why?
| Fatty Acids, Monounsaturated | 2 | 1998 | 47 | 0.080 |
Why?
| Hepatocytes | 1 | 2009 | 197 | 0.080 |
Why?
| Phosphorylation | 5 | 2016 | 1560 | 0.080 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2008 | 57 | 0.080 |
Why?
| Simaroubaceae | 1 | 2007 | 1 | 0.070 |
Why?
| HL-60 Cells | 2 | 1997 | 27 | 0.070 |
Why?
| Pharmacokinetics | 1 | 2007 | 26 | 0.070 |
Why?
| Monosaccharides | 1 | 2007 | 11 | 0.070 |
Why?
| Anthracenes | 1 | 2007 | 28 | 0.070 |
Why?
| Herpesvirus 8, Human | 1 | 2007 | 63 | 0.070 |
Why?
| Dendrimers | 1 | 2006 | 13 | 0.070 |
Why?
| Anti-Infective Agents | 1 | 2009 | 225 | 0.070 |
Why?
| Antibodies, Monoclonal | 2 | 2009 | 1262 | 0.070 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 2012 | 484 | 0.070 |
Why?
| DNA, Neoplasm | 2 | 2001 | 156 | 0.070 |
Why?
| Blotting, Western | 5 | 2008 | 1153 | 0.070 |
Why?
| Genes | 1 | 1987 | 223 | 0.070 |
Why?
| Anticarcinogenic Agents | 1 | 2007 | 67 | 0.070 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 269 | 0.070 |
Why?
| Heat-Shock Proteins | 1 | 1987 | 113 | 0.070 |
Why?
| Flavones | 1 | 2006 | 10 | 0.070 |
Why?
| Microsomes, Liver | 3 | 2012 | 57 | 0.070 |
Why?
| Calendula | 1 | 2006 | 1 | 0.070 |
Why?
| Case Management | 1 | 2006 | 62 | 0.070 |
Why?
| Candida albicans | 3 | 2013 | 55 | 0.070 |
Why?
| Patient Dropouts | 1 | 2006 | 65 | 0.070 |
Why?
| Purines | 1 | 2007 | 159 | 0.070 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 332 | 0.070 |
Why?
| Models, Biological | 3 | 2008 | 1647 | 0.070 |
Why?
| Protein Binding | 3 | 2001 | 1919 | 0.070 |
Why?
| Chromatography, Affinity | 2 | 1997 | 83 | 0.060 |
Why?
| Anticoagulants | 1 | 2009 | 545 | 0.060 |
Why?
| Transcription, Genetic | 2 | 1993 | 1317 | 0.060 |
Why?
| Genetic Variation | 1 | 1990 | 891 | 0.060 |
Why?
| Cell Growth Processes | 1 | 2005 | 52 | 0.060 |
Why?
| Asteraceae | 1 | 2005 | 19 | 0.060 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2005 | 38 | 0.060 |
Why?
| Alkaloids | 1 | 2005 | 22 | 0.060 |
Why?
| Liver | 2 | 2007 | 1693 | 0.060 |
Why?
| In Vitro Techniques | 3 | 2009 | 1044 | 0.060 |
Why?
| Clinical Trials as Topic | 2 | 2006 | 945 | 0.060 |
Why?
| Hypersensitivity, Delayed | 1 | 2004 | 52 | 0.060 |
Why?
| Diospyros | 1 | 2004 | 1 | 0.060 |
Why?
| Societies, Pharmaceutical | 1 | 2004 | 27 | 0.060 |
Why?
| Naphthoquinones | 1 | 2004 | 17 | 0.060 |
Why?
| Methylation | 2 | 2016 | 206 | 0.060 |
Why?
| Taxus | 1 | 2004 | 1 | 0.060 |
Why?
| Camptotheca | 1 | 2004 | 1 | 0.060 |
Why?
| Carcinoma | 1 | 2006 | 200 | 0.060 |
Why?
| Topoisomerase I Inhibitors | 1 | 2004 | 16 | 0.060 |
Why?
| Deoxycytidine | 1 | 2004 | 140 | 0.060 |
Why?
| Pharmaceutical Services | 1 | 2004 | 79 | 0.060 |
Why?
| Cell Survival | 4 | 2012 | 1026 | 0.060 |
Why?
| Leucine Zippers | 2 | 1993 | 16 | 0.060 |
Why?
| Stereoisomerism | 3 | 2009 | 91 | 0.060 |
Why?
| Male | 14 | 2016 | 56123 | 0.050 |
Why?
| Proteins | 2 | 2000 | 922 | 0.050 |
Why?
| History, 20th Century | 1 | 2004 | 276 | 0.050 |
Why?
| Patient Selection | 1 | 2006 | 656 | 0.050 |
Why?
| Cell Proliferation | 4 | 2012 | 2196 | 0.050 |
Why?
| Patient Compliance | 1 | 2006 | 524 | 0.050 |
Why?
| Membrane Potential, Mitochondrial | 2 | 2012 | 55 | 0.050 |
Why?
| Phloroglucinol | 1 | 2001 | 1 | 0.050 |
Why?
| Bridged Bicyclo Compounds | 1 | 2001 | 12 | 0.050 |
Why?
| Drug Antagonism | 1 | 2001 | 8 | 0.050 |
Why?
| Cytochrome P-450 CYP2C9 | 2 | 2012 | 18 | 0.050 |
Why?
| Evidence-Based Medicine | 1 | 2006 | 686 | 0.050 |
Why?
| Plastids | 1 | 2001 | 2 | 0.050 |
Why?
| Eubacterium | 1 | 2001 | 3 | 0.050 |
Why?
| Cytochrome P-450 CYP3A | 1 | 2001 | 62 | 0.050 |
Why?
| Cell Nucleus | 3 | 2010 | 554 | 0.050 |
Why?
| Spectrophotometry, Ultraviolet | 2 | 2011 | 75 | 0.050 |
Why?
| Peptide Fragments | 2 | 1997 | 675 | 0.050 |
Why?
| Escherichia coli | 3 | 1993 | 730 | 0.050 |
Why?
| Carcinogens | 1 | 2001 | 105 | 0.050 |
Why?
| Kidney | 1 | 1988 | 1208 | 0.050 |
Why?
| DNA, Single-Stranded | 2 | 1993 | 112 | 0.050 |
Why?
| Photosynthesis | 1 | 2001 | 66 | 0.050 |
Why?
| Family Practice | 1 | 2004 | 418 | 0.050 |
Why?
| Pharmacogenetics | 1 | 2001 | 153 | 0.050 |
Why?
| Sequence Homology, Amino Acid | 1 | 2001 | 352 | 0.050 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2000 | 68 | 0.040 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 2 | 2013 | 193 | 0.040 |
Why?
| Carcinoma, Hepatocellular | 2 | 1999 | 224 | 0.040 |
Why?
| Detergents | 1 | 2000 | 41 | 0.040 |
Why?
| Biocompatible Materials | 2 | 2006 | 379 | 0.040 |
Why?
| Glycosides | 2 | 2013 | 33 | 0.040 |
Why?
| Serine Endopeptidases | 1 | 2000 | 102 | 0.040 |
Why?
| Neoplasm Proteins | 2 | 2016 | 388 | 0.040 |
Why?
| Patient Education as Topic | 1 | 2004 | 686 | 0.040 |
Why?
| Esters | 1 | 2000 | 61 | 0.040 |
Why?
| Proteasome Endopeptidase Complex | 2 | 2011 | 136 | 0.040 |
Why?
| Mass Screening | 1 | 2006 | 1023 | 0.040 |
Why?
| Cation Exchange Resins | 1 | 1998 | 7 | 0.040 |
Why?
| Saccharomyces cerevisiae | 3 | 2009 | 482 | 0.040 |
Why?
| DNA Replication | 2 | 1997 | 204 | 0.040 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2011 | 167 | 0.040 |
Why?
| Arginine | 1 | 2000 | 241 | 0.040 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 1998 | 78 | 0.040 |
Why?
| Response Elements | 1 | 1999 | 83 | 0.040 |
Why?
| Gentamicins | 1 | 1998 | 43 | 0.040 |
Why?
| Thymidine | 2 | 1995 | 58 | 0.040 |
Why?
| Freezing | 1 | 1998 | 85 | 0.040 |
Why?
| Polyesters | 1 | 1998 | 65 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor Proteins | 2 | 2008 | 7 | 0.040 |
Why?
| Drug Costs | 1 | 1998 | 91 | 0.040 |
Why?
| Trehalose | 1 | 1997 | 29 | 0.040 |
Why?
| Cell Division | 2 | 1997 | 760 | 0.040 |
Why?
| Malondialdehyde | 1 | 1997 | 26 | 0.040 |
Why?
| Signal Transduction | 1 | 2010 | 4525 | 0.040 |
Why?
| Scattering, Radiation | 1 | 1997 | 92 | 0.040 |
Why?
| Phosphatidylethanolamines | 1 | 1997 | 66 | 0.040 |
Why?
| Plant Bark | 2 | 2009 | 11 | 0.040 |
Why?
| Aspergillus niger | 2 | 2009 | 8 | 0.040 |
Why?
| Freeze Drying | 1 | 1997 | 75 | 0.040 |
Why?
| Indonesia | 2 | 2009 | 18 | 0.040 |
Why?
| CCAAT-Enhancer-Binding Proteins | 1 | 1997 | 34 | 0.040 |
Why?
| Sucrose | 1 | 1997 | 91 | 0.040 |
Why?
| Enzyme Stability | 1 | 1997 | 73 | 0.040 |
Why?
| Proto-Oncogene Proteins c-myb | 1 | 1997 | 9 | 0.040 |
Why?
| Dimerization | 1 | 1997 | 177 | 0.040 |
Why?
| Histone Deacetylase 2 | 1 | 2016 | 7 | 0.040 |
Why?
| Lipid Peroxidation | 1 | 1997 | 138 | 0.040 |
Why?
| Histone Deacetylase 1 | 1 | 2016 | 16 | 0.040 |
Why?
| Protein Conformation | 2 | 1997 | 822 | 0.040 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 27 | 0.040 |
Why?
| Breast Neoplasms | 2 | 2006 | 1870 | 0.040 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 1359 | 0.030 |
Why?
| Binding Sites | 2 | 1997 | 1183 | 0.030 |
Why?
| Sequence Deletion | 1 | 1997 | 167 | 0.030 |
Why?
| Enzyme Activation | 3 | 2007 | 791 | 0.030 |
Why?
| Cytoplasm | 2 | 2008 | 255 | 0.030 |
Why?
| Proto-Oncogene Proteins c-jun | 2 | 1993 | 47 | 0.030 |
Why?
| KB Cells | 2 | 2007 | 4 | 0.030 |
Why?
| Precipitin Tests | 2 | 1997 | 90 | 0.030 |
Why?
| Jordan | 2 | 2006 | 3 | 0.030 |
Why?
| Artemia | 2 | 2006 | 8 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 319 | 0.030 |
Why?
| Drug Delivery Systems | 1 | 1998 | 301 | 0.030 |
Why?
| United States | 2 | 2004 | 12340 | 0.030 |
Why?
| Time Factors | 3 | 2008 | 6186 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 2 | 1993 | 181 | 0.030 |
Why?
| Butyric Acid | 1 | 1995 | 5 | 0.030 |
Why?
| Light | 1 | 1997 | 334 | 0.030 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1995 | 153 | 0.030 |
Why?
| Female | 8 | 2013 | 60076 | 0.030 |
Why?
| Glioblastoma | 2 | 2007 | 251 | 0.030 |
Why?
| Genes, Reporter | 1 | 1995 | 260 | 0.030 |
Why?
| Oxidation-Reduction | 1 | 1997 | 933 | 0.030 |
Why?
| Kinetics | 1 | 1997 | 1560 | 0.030 |
Why?
| Mice | 4 | 2012 | 15073 | 0.030 |
Why?
| Bacteriophage T7 | 1 | 1993 | 3 | 0.030 |
Why?
| Protein Sorting Signals | 1 | 1993 | 16 | 0.030 |
Why?
| DNA, Recombinant | 1 | 1993 | 42 | 0.030 |
Why?
| Adenovirus E1A Proteins | 1 | 1993 | 11 | 0.030 |
Why?
| Depression | 1 | 2001 | 1147 | 0.030 |
Why?
| DNA, Superhelical | 1 | 1993 | 11 | 0.030 |
Why?
| Kidney Tubules | 1 | 1994 | 107 | 0.030 |
Why?
| Phenotype | 1 | 2001 | 2858 | 0.030 |
Why?
| Rats | 4 | 1999 | 5035 | 0.030 |
Why?
| Nickel | 1 | 1993 | 51 | 0.030 |
Why?
| Haemonchus | 1 | 2012 | 1 | 0.030 |
Why?
| Glucose | 1 | 1997 | 904 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2016 | 531 | 0.030 |
Why?
| Optical Rotation | 1 | 2011 | 2 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1993 | 345 | 0.030 |
Why?
| Antibiotics, Antineoplastic | 1 | 2012 | 114 | 0.030 |
Why?
| Histones | 1 | 2016 | 539 | 0.030 |
Why?
| Spectrophotometry, Infrared | 1 | 2011 | 45 | 0.020 |
Why?
| Resorcinols | 1 | 2011 | 4 | 0.020 |
Why?
| Hydroxybenzoates | 1 | 2011 | 10 | 0.020 |
Why?
| Crystallography, X-Ray | 1 | 2013 | 408 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 1994 | 447 | 0.020 |
Why?
| RNA, Messenger | 1 | 1998 | 2581 | 0.020 |
Why?
| Epitopes | 1 | 1993 | 438 | 0.020 |
Why?
| Blood Proteins | 1 | 1993 | 238 | 0.020 |
Why?
| Gene Expression Regulation | 2 | 1993 | 2362 | 0.020 |
Why?
| Daunorubicin | 1 | 1990 | 24 | 0.020 |
Why?
| Caspase 8 | 1 | 2010 | 43 | 0.020 |
Why?
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 26 | 0.020 |
Why?
| Protein Kinases | 1 | 1992 | 306 | 0.020 |
Why?
| Drug Tolerance | 1 | 1990 | 79 | 0.020 |
Why?
| Transcription Factor RelA | 1 | 2010 | 83 | 0.020 |
Why?
| Phosphates | 1 | 1991 | 160 | 0.020 |
Why?
| Indoles | 1 | 2012 | 309 | 0.020 |
Why?
| Aporphines | 1 | 2009 | 1 | 0.020 |
Why?
| Micrococcus luteus | 1 | 2009 | 3 | 0.020 |
Why?
| Hydroxylation | 1 | 2009 | 28 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2011 | 477 | 0.020 |
Why?
| Liver Function Tests | 1 | 2010 | 105 | 0.020 |
Why?
| Spectrum Analysis | 1 | 2010 | 82 | 0.020 |
Why?
| Placebos | 1 | 2010 | 198 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2012 | 346 | 0.020 |
Why?
| Inhibitory Concentration 50 | 1 | 2009 | 78 | 0.020 |
Why?
| Mycobacterium tuberculosis | 1 | 2012 | 268 | 0.020 |
Why?
| Doxorubicin | 1 | 1990 | 290 | 0.020 |
Why?
| Antibody Specificity | 1 | 2009 | 180 | 0.020 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 49 | 0.020 |
Why?
| Acrolein | 2 | 1999 | 23 | 0.020 |
Why?
| Cell Line | 2 | 1994 | 2655 | 0.020 |
Why?
| Bacteria | 2 | 2005 | 731 | 0.020 |
Why?
| cdc25 Phosphatases | 1 | 2008 | 12 | 0.020 |
Why?
| Isomerism | 1 | 2008 | 42 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2008 | 188 | 0.020 |
Why?
| Microcirculation | 1 | 2008 | 138 | 0.020 |
Why?
| Drug Design | 1 | 2009 | 156 | 0.020 |
Why?
| Metallothionein | 1 | 1988 | 24 | 0.020 |
Why?
| Molecular Conformation | 1 | 2008 | 138 | 0.020 |
Why?
| Mycobacterium | 1 | 2009 | 103 | 0.020 |
Why?
| Cyclins | 1 | 2008 | 79 | 0.020 |
Why?
| Enzyme Induction | 1 | 1988 | 85 | 0.020 |
Why?
| Cell Differentiation | 1 | 1995 | 1706 | 0.020 |
Why?
| Peptides | 1 | 2013 | 862 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1988 | 376 | 0.020 |
Why?
| Leukemia P388 | 1 | 2007 | 7 | 0.020 |
Why?
| Dominican Republic | 1 | 2007 | 18 | 0.020 |
Why?
| Cells, Cultured | 3 | 1994 | 3916 | 0.020 |
Why?
| Amino Acids | 1 | 1991 | 455 | 0.020 |
Why?
| Rats, Inbred F344 | 1 | 1988 | 245 | 0.020 |
Why?
| DNA Topoisomerases, Type I | 1 | 1987 | 17 | 0.020 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 42 | 0.020 |
Why?
| Mice, Nude | 1 | 2008 | 639 | 0.020 |
Why?
| Angiogenesis Inhibitors | 1 | 2008 | 216 | 0.020 |
Why?
| Fluorescence | 1 | 2007 | 153 | 0.020 |
Why?
| Biological Assay | 1 | 2007 | 114 | 0.020 |
Why?
| Capsules | 1 | 2006 | 36 | 0.020 |
Why?
| Antigens, Viral | 1 | 2007 | 174 | 0.020 |
Why?
| Blotting, Northern | 2 | 1998 | 194 | 0.020 |
Why?
| Species Specificity | 1 | 1988 | 555 | 0.020 |
Why?
| Fluorescent Antibody Technique | 1 | 2007 | 399 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2009 | 1165 | 0.020 |
Why?
| Plant Leaves | 1 | 2007 | 103 | 0.020 |
Why?
| Glutathione | 1 | 1988 | 303 | 0.020 |
Why?
| Solubility | 1 | 2006 | 227 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2008 | 504 | 0.020 |
Why?
| Caspases | 1 | 2007 | 245 | 0.020 |
Why?
| Amphotericin B | 1 | 2005 | 32 | 0.020 |
Why?
| Microtubule-Associated Proteins | 1 | 2007 | 176 | 0.020 |
Why?
| Cell Death | 1 | 2007 | 324 | 0.020 |
Why?
| Plant Components, Aerial | 1 | 2005 | 3 | 0.020 |
Why?
| Biological Transport | 1 | 2006 | 373 | 0.020 |
Why?
| Drosophila | 1 | 1987 | 132 | 0.020 |
Why?
| Social Work | 1 | 2006 | 75 | 0.020 |
Why?
| Double-Blind Method | 1 | 2010 | 1665 | 0.020 |
Why?
| Telephone | 1 | 2006 | 153 | 0.020 |
Why?
| Culture | 1 | 2006 | 126 | 0.020 |
Why?
| Pilot Projects | 1 | 2010 | 1374 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 934 | 0.020 |
Why?
| Flow Cytometry | 1 | 2008 | 1058 | 0.020 |
Why?
| Cognition Disorders | 1 | 2009 | 479 | 0.020 |
Why?
| Coumarins | 1 | 2004 | 20 | 0.020 |
Why?
| Fluorouracil | 1 | 2004 | 151 | 0.010 |
Why?
| Chemotherapy, Adjuvant | 1 | 2004 | 334 | 0.010 |
Why?
| Methotrexate | 1 | 2004 | 228 | 0.010 |
Why?
| Models, Molecular | 1 | 2008 | 1391 | 0.010 |
Why?
| Poverty | 1 | 2006 | 444 | 0.010 |
Why?
| Social Support | 1 | 2006 | 541 | 0.010 |
Why?
| 14-3-3 Proteins | 1 | 2000 | 13 | 0.010 |
Why?
| Colorectal Neoplasms | 1 | 2006 | 617 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2007 | 2814 | 0.010 |
Why?
| Cations | 1 | 2000 | 78 | 0.010 |
Why?
| Ethacrynic Acid | 1 | 1998 | 1 | 0.010 |
Why?
| Brain Neoplasms | 1 | 2006 | 979 | 0.010 |
Why?
| Absorption | 1 | 1998 | 53 | 0.010 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2006 | 964 | 0.010 |
Why?
| Chemistry, Pharmaceutical | 1 | 1998 | 99 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1998 | 182 | 0.010 |
Why?
| Immune Sera | 1 | 1997 | 80 | 0.010 |
Why?
| Adult | 1 | 1999 | 30814 | 0.010 |
Why?
| Osteomyelitis | 1 | 1998 | 105 | 0.010 |
Why?
| Oxidants | 1 | 1997 | 113 | 0.010 |
Why?
| Immunoblotting | 1 | 1997 | 283 | 0.010 |
Why?
| Infant | 1 | 2010 | 8002 | 0.010 |
Why?
| Child, Preschool | 1 | 2010 | 9174 | 0.010 |
Why?
| Rabbits | 1 | 1997 | 754 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2006 | 6437 | 0.010 |
Why?
| Lung Neoplasms | 1 | 2006 | 2207 | 0.010 |
Why?
| Growth Substances | 1 | 1994 | 136 | 0.010 |
Why?
| Activating Transcription Factors | 1 | 1993 | 2 | 0.010 |
Why?
| Epithelium | 1 | 1994 | 297 | 0.010 |
Why?
| Baculoviridae | 1 | 1992 | 45 | 0.010 |
Why?
| Zinc Fingers | 1 | 1992 | 45 | 0.010 |
Why?
| Moths | 1 | 1992 | 33 | 0.010 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1992 | 171 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 1997 | 2262 | 0.010 |
Why?
| Adolescent | 1 | 2010 | 17949 | 0.010 |
Why?
| Genetic Vectors | 1 | 1992 | 297 | 0.010 |
Why?
| Swine | 1 | 1994 | 706 | 0.010 |
Why?
| Child | 1 | 2010 | 18550 | 0.010 |
Why?
| Zinc | 1 | 1993 | 257 | 0.010 |
Why?
| Protein Processing, Post-Translational | 1 | 1992 | 400 | 0.010 |
Why?
| Aged | 1 | 2006 | 19296 | 0.000 |
Why?
| Epithelial Cells | 1 | 1994 | 965 | 0.000 |
Why?
| Middle Aged | 1 | 2006 | 27080 | 0.000 |
Why?
| Mutation | 1 | 1993 | 3369 | 0.000 |
Why?
|
|
Kroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|